Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 6751 AL 6765

Protein S-sulfhydration: Mechanisms and therapeutic implications in Alzheimer's disease and Parkinson's disease

Guo J, Shi C, Yu C, Wang Y, He M.

Free Radic Biol Med. 2026 Mar 16;246:431-441. doi: 10.1016/j.freeradbiomed.2026.01.033. Epub 2026 Jan 20.

Radical Revelations: The Interplay of Nitrosative Stress, the Endocannabinoid System, and Treatment of Age-Related Disorders

Davis A, Casmedes IY, Burton MD.

Int J Mol Sci. 2026 Mar 20;27(6):2813. doi: 10.3390/ijms27062813.

Neuroprotective role of cyanidin in Alzheimer's and Parkinson's disease: current insights and the road ahead

Bashir B, Andotra N, Sharma P, Sharma T, Chauhan S, Awasthi A, Singh S, Singh TG, Singh SK, Vishwas S.

Inflammopharmacology. 2026 May 23. doi: 10.1007/s10787-026-02271-w. Online ahead of print.

Neuroprotective Herbs Associated with Parkinson's and Alzheimer's Disease

Marțiș GS, Ungur RA, Pop A, Bordean EM, Pașca C, Borda IM.

Nutrients. 2026 Jan 29;18(3):439. doi: 10.3390/nu18030439.

The effect of GLP-1 receptor agonists on autophagy: insights gathered from research evaluating neurodegenerative disorders with these agents

Sioufi MC, Heroiu I, Wong S, Le GH, Dri CE, Zheng YJ, Teopiz KM, Rhee TG, Lo HKY, Guillen-Burgos HF, McIntyre RS.

Acta Neuropsychiatr. 2026 Feb 13;38:e24. doi: 10.1017/neu.2026.10060.

The Rare Marine Bioactive Compounds in Neurological Disorders and Diseases: Is the Blood-Brain Barrier an Obstacle or a Target?

Diao X, Han H, Li B, Guo Z, Fu J, Wu W.

Mar Drugs. 2023 Jul 18;21(7):406. doi: 10.3390/md21070406.

The Role of Hydrogen Sulfide in Regulation of Cell Death following Neurotrauma and Related Neurodegenerative and Psychiatric Diseases

Rodkin S, Nwosu C, Sannikov A, Raevskaya M, Tushev A, Vasilieva I, Gasanov M.

Int J Mol Sci. 2023 Jun 28;24(13):10742. doi: 10.3390/ijms241310742.

Natural products for the treatment of neurodegenerative diseases

Cui D, Chen Y, Ye B, Guo W, Wang D, He J.

Phytomedicine. 2023 Dec;121:155101. doi: 10.1016/j.phymed.2023.155101. Epub 2023 Sep 18.

GPCR interactions involving metabotropic glutamate receptors and their relevance to the pathophysiology and treatment of CNS disorders

Nicoletti F, Di Menna L, Iacovelli L, Orlando R, Zuena AR, Conn PJ, Dogra S, Joffe ME.

Neuropharmacology. 2023 Sep 1;235:109569. doi: 10.1016/j.neuropharm.2023.109569. Epub 2023 May 2.

Effect of arctigenin on neurological diseases: A review

Li M, Jiang H, Wang Y, Xu Z, Xu H, Chen Y, Zhu J, Lin Z, Zhang M.

J Ethnopharmacol. 2023 Oct 28;315:116642. doi: 10.1016/j.jep.2023.116642. Epub 2023 May 24.

Research Progress of Nanocarriers for the Treatment of Alzheimer's Disease

Li L, Zhang J, Huang X, Du J, Tu Z, Wu H, Liu X, Yuan M.

Curr Pharm Des. 2023;29(2):95-115. doi: 10.2174/1381612829666221216114912.

Monoclonal antibodies for the management of central nervous system diseases: clinical success and future strategies

Singh Gautam A, Pandey SK, Lasure V, Dubey S, Singh RK.

Expert Opin Biol Ther. 2023 Jul-Dec;23(7):603-618. doi: 10.1080/14712598.2023.2227378. Epub 2023 Jun 27.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias